Healthcare Global Enterprises Limited — Updates, 24-05-2025: Press Release

HealthCare Global Enterprises has announced a board meeting to approve the financial results for the quarter and half-year. Q4 revenue rose 18% to Rs. 5851 Mn with adjusted EBITDA up 14%, while PAT fell 66% due to one-time M&A costs. FY25 revenue grew 16% to Rs. 22228 Mn; adjusted EBITDA increased 17% to Rs. 3963 Mn, but PAT declined 8%. Established and emerging centers expanded 17% and 30%. Outpatient footfall and chemo sessions increased 14% and 19%. The company is enhancing molecular diagnostics and expanding through hospital acquisitions, focusing on early cancer detection and precision medicine.